Brett R Goldsmith

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Graphene Electronics. Top assignees: Cardea Bio, Inc., University of Pennsylvania, Nanomedical Diagnostics, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett R Goldsmith. Retrieved from https://idiyas.com/inventor/brett-r-goldsmith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 7)

% Patents Active = 96.3

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 185(Granted Patents)

Location History:

Philadelphia, PA (US) (2017 - 2021)
San Diego, CA (US) (2015 - 2024)

Company Filing History:

University of Pennsylvania

patents

6 out of 8

Nanomedical Diagnostics, Inc.

Institute for Cancer Research

University of Illinois

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Graphene

Bioelectronic Devices

Field Effect Transistors

DNA Sequencing

Chemical Sensors

Nanosensors

Genome Manipulation

Enzymatic Detection

Carbon Nanotubes

2D FETs

Olfactory Receptors

Silicon CMOS

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12546769 - Graphene-biomolecule bioelectronic devices (2026-02-10),

2. 12372521 - Chemically differentiated sensor array (2025-07-29),

3. 12345677 - Integrated circuit with 2D FETs for direct and indirect target signal measurement (2025-07-01),

4. 12298301 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2025-05-13),

5. 11921112 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2024-03-05),

6. 11782057 - Ic with graphene fet sensor array patterned in layers above circuitry formed in a silicon based cmos wafer (2023-10-10),

7. 11732296 - Two-dimensional channel FET devices, systems, and methods of using the same for sequencing nucleic acids (2023-08-22),

8. 11713455 - Enhanced selection of efficient targeted genome manipulating agents (2023-08-01),

9. 11561197 - Electronic detection of a target based on enzymatic cleavage of a reporter moiety (2023-01-24),

10. 11536722 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2022-12-27),

11. 11215580 - System and method for DNA sequencing and blood chemistry analysis (2022-01-04),

12. 11119097 - Graphene-biomolecule bioelectronic devices (2021-09-14),

13. 11092598 - Chemically differentiated sensor array (2021-08-17),

14. 11056343 - Providing a temporary protective layer on a graphene sheet (2021-07-06),

15. 11016088 - Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same (2021-05-25),

Title: Innovations by Brett R. Goldsmith: A Pioneer in Chemically-Sensitive Technology

Introduction

Brett R. Goldsmith, located in San Diego, CA, is a prolific inventor with an impressive portfolio of 23 patents. His innovative work primarily focuses on the development of chemically-sensitive field effect transistors, showcasing advancements in biosensor integrated circuit technology.

Latest Patents

Among his latest patents is a groundbreaking apparatus that includes a biosensor integrated circuit (IC) chip equipped with sensing zones designed to process liquids containing biological analytes. This chip features advanced passivation and etch stop layers, along with an array of liquid-gated field effect transistors with a 2D channel, enabling the precise measurement of biological analytes through monitoring changes in transconductance curves.

Another notable invention is an integrated circuit chip that integrates a graphene field effect transistor (gFET) sensor array above a silicon-based CMOS wafer. This design allows for direct contact between a sample liquid and the graphene channels, forming a liquid gate over the channels, which furthers the capabilities of sensitive biological measurements.

Career Highlights

Throughout his career, Goldsmith has made significant contributions to the field by collaborating with innovative companies such as Cardea Bio, Inc. and Nanomedical Diagnostics, Inc. His work has not only advanced the capabilities of biosensors but has also impacted various applications in medical diagnostics and health monitoring.

Collaborations

Goldsmith has collaborated with talented professionals like Mitchell Lerner and Alan T. Johnson, enhancing the collaborative environment of technological innovation. These relationships have been essential to the successful development and implementation of biosensor technologies and other advanced integrated circuit designs.

Conclusion

Brett R. Goldsmith's contributions to the field of chemically-sensitive technology highlight his commitment to innovation and excellence. His patents and collaborative efforts have paved the way for new advancements in biosensor technology and demonstrate the significant impact that effective collaboration and invention can have on scientific progress.

Profile summary based on public USPTO records.